Which treatment modality should we choose for advanced hepatocellular carcinoma?.
10.3350/kjhep.2010.16.4.353
- Author:
Do Young KIM
1
Author Information
1. Department of Internal Medicine, Yonsei Liver Cancer Special Clinic, Yonsei University College of Medicine, Seoul, Korea. dyk1025@yuhs.ac
- Publication Type:Editorial ; Comment
- Keywords:
Hepatocellular carcinoma;
Transarterial chemoembolization;
Hepatic arterial infusion chemotherapy
- MeSH:
Adult;
Aged;
Antineoplastic Agents/administration & dosage;
Antineoplastic Combined Chemotherapy Protocols;
Benzenesulfonates/administration & dosage;
Carcinoma, Hepatocellular/mortality/*therapy;
Chemoembolization, Therapeutic;
Cisplatin/administration & dosage;
Fluorouracil/administration & dosage;
Humans;
Infusions, Intra-Arterial;
Liver Neoplasms/mortality/*therapy;
Middle Aged;
Pyridines/administration & dosage;
Survival Rate
- From:The Korean Journal of Hepatology
2010;16(4):353-354
- CountryRepublic of Korea
- Language:English
-
Abstract:
No abstract available.
